These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19411384)

  • 1. Hallucinations in the context of varenicline withdrawal.
    Laine P; Marttila J; Lindeman S
    Am J Psychiatry; 2009 May; 166(5):619-20. PubMed ID: 19411384
    [No Abstract]   [Full Text] [Related]  

  • 2. Varenicline and pheochromocytoma.
    Hukkanen J; Ukkola O; Benowitz NL
    Ann Intern Med; 2010 Mar; 152(5):335-6. PubMed ID: 20194248
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline: the French experience after 6 months.
    Prescrire Int; 2009 Feb; 18(99):25. PubMed ID: 19396936
    [No Abstract]   [Full Text] [Related]  

  • 6. Varenicline for smoking cessation.
    Tonstad S
    Expert Rev Neurother; 2007 Feb; 7(2):121-7. PubMed ID: 17286546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of recurrent depression as a result of treatment with varenicline.
    Popkin MK
    Am J Psychiatry; 2008 Jun; 165(6):774. PubMed ID: 18519539
    [No Abstract]   [Full Text] [Related]  

  • 8. New kid on the block: Chantix for smoking cessation.
    Rankin KV
    Tex Dent J; 2008 May; 125(5):432-3. PubMed ID: 18561798
    [No Abstract]   [Full Text] [Related]  

  • 9. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the dose of varenicline in patients who do not respond to the standard dose.
    Jiménez-Ruiz CA; Barrios M; Peña S; Cicero A; Mayayo M; Cristóbal M; Perera L
    Mayo Clin Proc; 2013 Dec; 88(12):1443-5. PubMed ID: 24290118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
    Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
    Kistler CE; Goldstein AO
    Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928
    [No Abstract]   [Full Text] [Related]  

  • 15. Varenicline (Chantix) for tobacco dependence.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of varenicline in patients with cardiovascular disease.
    Haber SL; Boomershine V; Raney E
    J Pharm Pract; 2014 Feb; 27(1):65-70. PubMed ID: 24080536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
    Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longer course of varenicline therapy improves smoking cessation rates.
    Lee JH; Jones PG; Bybee K; O'Keefe JH
    Prev Cardiol; 2008; 11(4):210-4. PubMed ID: 19476573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Varenicline--a new drug for smoking cessation].
    Tønnesen P
    Ugeskr Laeger; 2007 Nov; 169(47):4051-2. PubMed ID: 18078657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.